Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22025146

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2012 Jan 10
First author
Wells SA Jr

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Aug 20;31(24):3049
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2012 Jan 10;30(2):119-21. doi: 10.1200/JCO.2011.37.8638.
    note
    Source null
    related pmid
    22025155
    relationship
    Comment in
  3. citation
    Nat Rev Endocrinol. 2011 Nov 15;8(1):1. doi: 10.1038/nrendo.2011.198.
    note
    Source null
    related pmid
    22083086
    relationship
    Comment in
  4. citation
    Nat Rev Clin Oncol. 2011 Nov 22;9(1):5. doi: 10.1038/nrclinonc.2011.174.
    note
    Source null
    related pmid
    22104984
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2012 Jan 10;30(2):200-2. doi: 10.1200/JCO.2011.38.7639.
    note
    Source null
    related pmid
    22162569
    relationship
    Comment in
  6. citation
    J Clin Oncol. 2012 Jun 10;30(17):2165; author reply 2166-7. doi: 10.1200/JCO.2012.42.3160.
    note
    Source null
    related pmid
    22564994
    relationship
    Comment in

Authors and identifiers

  1. name
    Wells SA Jr
    type
    Author
  2. name
    Robinson BG
    type
    Author
  3. name
    Gagel RF
    type
    Author
  4. name
    Dralle H
    type
    Author
  5. name
    Fagin JA
    type
    Author
  6. name
    Santoro M
    type
    Author
  7. name
    Baudin E
    type
    Author
  8. name
    Elisei R
    type
    Author
  9. name
    Jarzab B
    type
    Author
  10. name
    Vasselli JR
    type
    Author
  11. name
    Read J
    type
    Author
  12. name
    Langmuir P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wells SA Jr
    type
    Author
  2. name
    Robinson BG
    type
    Author
  3. name
    Gagel RF
    type
    Author
  4. name
    Dralle H
    type
    Author
  5. name
    Fagin JA
    type
    Author
  6. name
    Santoro M
    type
    Author
  7. name
    Baudin E
    type
    Author
  8. name
    Elisei R
    type
    Author
  9. name
    Jarzab B
    type
    Author
  10. name
    Vasselli JR
    type
    Author
  11. name
    Read J
    type
    Author
  12. name
    Langmuir P
    type
    Author
bibliography ids
  1. nci-bib-f6cdc5b1a89771831551bbfa
book metadata
content sha256
bf2aea31cb449d8e461dd3c50b31e1510126e7317e11e332e045a82643bd6f17
document type
citation
dois
  1. 10.1200/JCO.2011.35.5040
electronic publication date
display
2011 Oct 24
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:22025146
immutable id
pubmed:22025146@bf2aea31cb449d8e461dd3c50b31e1510126e7317e11e332e045a82643bd6f17
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
2
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
134-41
volume
30
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Aug 20;31(24):3049
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2012 Jan 10;30(2):119-21. doi: 10.1200/JCO.2011.37.8638.
    note
    Source null
    related pmid
    22025155
    relationship
    Comment in
  3. citation
    Nat Rev Endocrinol. 2011 Nov 15;8(1):1. doi: 10.1038/nrendo.2011.198.
    note
    Source null
    related pmid
    22083086
    relationship
    Comment in
  4. citation
    Nat Rev Clin Oncol. 2011 Nov 22;9(1):5. doi: 10.1038/nrclinonc.2011.174.
    note
    Source null
    related pmid
    22104984
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2012 Jan 10;30(2):200-2. doi: 10.1200/JCO.2011.38.7639.
    note
    Source null
    related pmid
    22162569
    relationship
    Comment in
  6. citation
    J Clin Oncol. 2012 Jun 10;30(17):2165; author reply 2166-7. doi: 10.1200/JCO.2012.42.3160.
    note
    Source null
    related pmid
    22564994
    relationship
    Comment in
outcomes validated
false
pmid
22025146
provenance
batch id
2529ef2eca926738ab13
provider
NCBI PubMed ESummary
record sha256
5b702389fee18df5541cf8bc9bb6a801be2d75f53d3fc69c0095cd68b3e62ade
response sha256
9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
retrieved at
2026-09-09T23:46:42.856296+00:00
publication date
display
2012 Jan 10
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22025146/
title
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.

Preserved source evidence · Not medical advice